RefleXion Highlights Clinical Study Results for Future Prostate Cancer Treatment

[ad_1]

oncology.pencis.com/” target=”_blank”>

oncology.pencis.com/” target=”_blank”>

oncology.pencis.com/” target=”_blank”>July 3, 2023 — RefleXion Medical, Inc., a therapeutic oncology company, today announced that results of a prospective investigator-initiated clinical imaging study conducted on its X1 platform by City of Hope using positron emission tomography (PET) were presented on June 24 during an oral session at the Society of Nuclear Medicine and Medical Imaging (SNMMI) annual meeting in Chicago. The study results serve as the foundation for evaluating the use of RefleXion’s SCINTIX biology-guided radiotherapy with a prostate-specific PET radiotracer for controlling external-beam radiotherapy delivery to prostate cancer tumor targets. City of Hope, one of the largest cancer Research and treatment organizations in the U.S., is among the first in the nation to adopt this new radiotherapy technology that has the potential to change the way metastatic cancer patients are treated. 

oncology.pencis.com/” target=”_blank”>Recently cleared by the U.S. Food and Drug Administration (FDA), SCINTIX technology is the first and only cancer therapy that uses each cancer’s unique biology to autonomously determine where to deliver radiotherapy, second-by-second, during the actual cancer treatment to indicated solid tumors of any stage. SCINTIX therapy uses signals produced by a PET radiotracer interacting with cancer cells to control delivery of external-beam radiotherapy to tumor targets. 

oncology.pencis.com/” target=”_blank”>The prostate-specific PET radiotracer used in the presented study – 18F-DCFPyL (PyL) – binds to prostate-specific membrane antigen (PSMA), a protein that is expressed in significantly elevated amounts by prostate cancer cells. Also recently approved by the FDA for diagnosing and staging prostate cancer, PyL can accurately and precisely pinpoint tumors in both the prostate and in other body areas where the cancer may have spread or metastasized. 

oncology.pencis.com/” target=”_blank”>“It is well established that PyL exquisitely detects tumors present in patients with prostate cancer, but targeting and treating those tumors can be challenging using existing radiotherapy approaches,” said Jeffrey Wong, M.D., professor of the Department of Radiation oncology and the Department of Immunology and Theranostics at City of Hope, and principal investigator of the RefleXion-supported PyL imaging study. “SCINTIX therapy could overcome these barriers, and our study results support continued exploration of leveraging PyL’s precision to expand SCINTIX therapy to patients with prostate cancer.” 

oncology.pencis.com/” target=”_blank”>The prospective PyL imaging study established that tumors arising from prostate cancer could be visualized on the RefleXion X1 platform using signals from PyL consistent with PyL diagnostic imaging studies, and that SCINTIX treatment plans could be generated using these data. PSMA-directed SCINTIX treatment plans also met conventional radiotherapy organ dose constraints, suggesting the ability to spare nearby organs and other healthy tissue from potentially damaging radiation. SCINTIX therapy is currently cleared for use with 18F fludeoxyglucose (FDG), a common PET radiotracer, to treat primary and metastatic tumors in the lung and bone. 

oncology.pencis.com/” target=”_blank”>“We look forward to offering FDG-directed SCINTIX therapy to our patients in the next several weeks,” said Terence Williams, M.D., Ph.D., professor and chair of City of Hope’s Department of Radiation oncology. “As early collaborators in evaluating SCINTIX technology, it is gratifying to see Research and clinical development efforts already advancing it toward another patient population in great need of improved radiotherapy approaches using the well-characterized benefits of PyL.” 

oncology.pencis.com/” target=”_blank”>For more information:https://oncology.pencis.com/

[ad_2]

Source link

¿Comer alimentos a la parrilla o asados puede provocar cáncer?

[ad_1]

Para muchas personas, las hamburguesas asadas o las verduras crujientes son los platos favoritos. Pero, ¿comer alimentos a la parrilla o asados o alimentos cocinados a altas temperaturas puede afectar al riesgo de desarrollar cáncer?

Se encuentran varios tipos de sustancias químicas en carnes a la parrilla, asadas y bien cocidas, así como en algunos alimentos a base de plantas horneados, tostados o fritos cuando se cocinan a altas temperaturas. Aquí encontrará información sobre cuáles son estas sustancias químicas, cómo pueden afectar al riesgo de desarrollar cáncer y qué puede hacer para reducir su exposición a sustancias químicas al cocinar.

¿Cuáles son las sustancias químicas que se encuentran en los alimentos a la parrilla o en los alimentos cocinados a altas temperaturas?

Dos sustancias químicas, los hidrocarburos aromáticos policíclicos (HAP) y las aminas heterocíclicas (AHC), se desarrollan de forma natural al cocinar carne. Cuando cocina carne, la grasa y el jugo gotean en la bandeja de goteo de la parrilla, lo que provoca llamas y humo que contienen HAP. Esto, a su vez, recubre la carne con HAP. Los HAP también se encuentran en los alimentos ahumados, el humo del tabaco y el escape del auto. Mientras tanto, las AHC se producen de forma natural cuando se calienta carne, como carne de res, pollo, cerdo o pescado, a altas temperaturas.

Otra sustancia química llamada acrilamida se desarrolla de forma natural al cocinar, tostar o freír papas u otros alimentos a base de plantas a altas temperaturas. La acrilamida es una sustancia química que se forma cuando los azúcares reaccionan con aminoácidos en los alimentos que se hornean, fritan o tuestan. Puede encontrar acrilamida en papas fritas u horneadas, galletas y otros productos horneados, y café. El agua potable y el humo del tabaco también contienen acrilamida, y las personas que fuman tienen niveles más altos de biomarcadores de acrilamida en la sangre que los no fumadores, según un estudio de 2010 sobre Perspectivas de salud medioambiental (en inglés).

Si desea obtener más información sobre qué alimentos contienen acrilamida, la Food and Drug Administration (FDA, Administración de Alimentos y Medicamentos) de los EE. UU. publica en línea el contenido de acrilamida en miles de alimentos (en inglés).

¿Pueden los HAP y las ACH causar cáncer?

En estudios con animales, los roedores que siguieron una dieta con dosis elevadas de HAP y AHC desarrollaron varios tipos diferentes de cáncer. Por ejemplo, en un estudio publicado en la revista Carcinogenesis (en inglés), los roedores alimentados con AHC en su dieta tenían más probabilidades de desarrollar cáncer de mama y cáncer de colon. Sin embargo, los estudios en seres humanos no han demostrado que los HAP o las AHC causen cáncer, y esta sigue siendo un área de investigación en curso.

El estudio de estas sustancias químicas en humanos es especialmente difícil porque es difícil identificar la cantidad exacta de HAP o AHC que una persona consume basándose en cuestionarios sobre su ingesta diaria de alimentos. Además, los niveles de HAP y de AHC pueden variar según el tipo de carne, la duración de la cocción y la temperatura de cocción. Por último, la forma en que su cuerpo metaboliza estas sustancias químicas o su exposición a estas sustancias químicas en su entorno pueden diferir de la de otra persona. Para algunas personas, esto podría afectar probablemente a su riesgo de desarrollar cáncer.

“No hay una recomendación clara sobre lo que es una cantidad segura (para consumir),” dice Julie Lanford, MPH, RD, CSO, LDN, una dietista registrada y la autora y creadora de CancerDietitian.com. Pero Lanford no recomienda evitar por completo las carnes a la parrilla. En su lugar, aconseja a las personas que cocinan a la parrilla con más frecuencia, como una o dos veces a la semana, que seleccionen diversos alimentos, como verduras, pescado cocido en papel de aluminio o carnes bajas en grasa, para reducir su exposición a HAP y AHC.

Otras formas de reducir posiblemente la exposición a estas sustancias químicas incluyen:

  • Intentar evitar las llamaradas que pueden carbonizar la carne
  • Precocer parcialmente las carnes para reducir el tiempo en la parrilla
  • Marinar la carne previamente para proporcionar una capa protectora contra estas sustancias químicas
cancer.net/sites/cancer.net/files/julie-lanford-circle.png” alt=”” width=”100″ height=”100″/>

Coma muchas frutas, verduras, cereales integrales, fríjoles, frutos secos y semillas. Si puede equilibrar los alimentos que podrían tener un mayor riesgo de carcinógenos con grandes cantidades de alimentos buenos, saludables y nutritivos, obtendrá el equilibrio adecuado”.–Julie Lanford, MPH, RD, CSO, LDN, una nutricionista registrada y la autora y creadora de CancerDietitian.com

¿Puede la acrilamida causar cáncer?

La acrilamida se identificó por primera vez en alimentos en 2002 (en inglés) y, aunque probablemente no sea una sustancia química nueva, desde entonces han ido aumentando los estudios de sus efectos sobre la salud.

En estudios con animales, se ha descubierto que los niveles altos de acrilamida causan varios tipos de cáncer, según la FDA (en inglés). Sin embargo, los estudios en personas no son concluyentes. Esto podría deberse a la dificultad para calcular el nivel de ingesta de acrilamida en la dieta de una persona. Además, los niveles de acrilamida en los alimentos pueden variar en función de la temperatura de cocción, la duración de la cocción, el almacenamiento de los alimentos y otros factores.

El panel de la Autoridad Europea de Seguridad Alimentaria (en inglés) y la Organización Conjunta de Agricultura y Alimentos de las Naciones Unidas/el Comité Experto de la Organización Mundial de la Salud sobre Aditivos Alimentarios (en inglés) categorizan la acrilamida como una inquietud y recomiendan seguir estudiando el posible riesgo de cáncer en las personas. Mientras tanto, la Agencia Internacional para la Investigación del Cáncer (en inglés) considera que la acrilamida es un probable carcinógeno humano, y el Programa Nacional de Toxicología de los EE. UU. (en inglés) clasifica la acrilamida como “previsto razonablemente como carcinógeno humano”.

La FDA no publica qué niveles de acrilamida son aceptables en una dieta y no aconseja dejar de comer alimentos con acrilamida. En su lugar, se recomienda seguir una dieta equilibrada y saludable que contenga una variedad de verduras, frutas, cereales, productos lácteos sin grasa o bajos en grasa y proteínas.

Sin embargo, si desea reducir la acrilamida en su dieta, la FDA le ofrece estos consejos:

  • Tueste el pan hasta que esté de un marrón dorado en lugar de uno oscuro.
  • Siga las instrucciones de la etiqueta de los alimentos para freír o cocinar alimentos congelados, como las papas fritas, y evite sobrecocinarlos.
  • Almacene las papas en una zona fresca y seca, pero no en el refrigerador; esto puede aumentar la acrilamida durante la cocción.

La información de esta publicación se basa en la investigación actual y en las opiniones de expertos disponibles hoy en día. Estos hallazgos pueden cambiar a medida que surjan más investigaciones sobre este tema.

[ad_2]

cancer.net/node/42340″>Source link

Tumor vs Cancer



Tumor vs. Cancer  

More information – https://oncologyandcancerresearch.blogspot.com/

International Conference on Oncology and Cancer Research:- https://oncology.pencis.com/
Award Nomination link: https://x-i.me/oan
Abstract Submission link: https://x-i.me/srimonco

For Inquiries: oncology@pencis.com

 #shorts #shortsvideo  #breastcancer #prostatecancer #lungcancer #coloncancer #ovariancancer #pancreaticcancer #leukemia #lymphoma     #OncologyConference #CancerResearch #OncologyAwards #CancerTreatment #OncologyCommunity #CancerCare #OncologyEducation #CancerSurvivorship #OncologyInnovation #CancerAwareness #OncologyLeadership #CancerPrevention #OncologyExcellence #CancerBreakthroughs #OncologyCollaboration #CancerAdvancements #OncologyImpact #CancerPatientsFirst #OncologyFuture #OncologyInspiration #CancerFighters #OncologyHeroes #CancerAwarenessMonth  #OncologyProgress #CancerSolutions #OncologyExperts #CancerSurvivors  #shorts #shortsvideo #cancerConference #OncologyConference #pencis #oncologyconference  #CardioOnc  #radonc #medonc #caxtx #GeriOnc #psyonc #oncorn #hsronc #camets #cancer #fuckcancer #cancersucks #breastcancerawareness #breastcancer #cancermemes #cancerousmemes #cancersurvivor #cancerawareness #cancerdemama #breastcancerawarenessmonth #cancerresearch #fightcancer #childhoodcancerawareness #beatcancer #childhoodcancer #cancerseason #breastcancersurvivor #cancerfree #cancerfighter #cancerous #fcancer #cancerwarrior #teamcancer #ovariancancer #americancancersociety #standuptocancer #cancerresearchuk #cancersupport #skincancer #cancermeme #cancer #feminismiscancer #curecancer #anticancer #cancerzodiac #prostatecancer #cancers #fucancer #pediatriccancer  #cancerawareness #beatcancer #cancersucks #cancerresearch #cancerfighter #cancerwarrior #cancertreatment #cancersurvivor #cancerprevention #cancerawarenessmonth #cancerpatientsupport #breastcancer #prostatecancer #lungcancer #coloncancer #ovariancancer #pancreaticcancer #leukemia #lymphoma #melanoma #braincancer #childhoodcancer #cancerfree #oncology #cancercare #cancerdiagnosis #cancerribbon #cancerjourney

CONNECT HERE:-

Facebook  : https://www.facebook.com/Conference-101261931798599
twitter        :https://twitter.com/Samirabellil
pinterest    : https://in.pinterest.com/OncologyandCancerResearch/
Blog          :https://oncologyandcancerresearch.blogspot.com/
tumblr       :https://www.tumblr.com/blog/view/cancer-researcher
instagram :https://www.instagram.com/oncology_researcher/
linkedin     : https://www.linkedin.com/in/cathenna-malia-a20834219/

source

Tumour growth can be prevented by removing excess chromosomes from cancer cells: Study

[ad_1]

Tumour growth can be prevented by removing excess chromosomes from cancer cells: Study(Shutterstock)

According to a recent Yale study, cancer cells with additional chromosomes rely on those chromosomes for tumour formation, and removing them stops the cells from growing tumours. The results, according to the researchers, point to the possibility of a novel cancer treatment strategy that specifically targets additional chromosomes. The study was published in the journal Science.

Human cells typically have 23 pairs of chromosomes; extra chromosomes are an anomaly known as aneuploidy.

“If you look at normal skin or normal lung tissue, for example, 99.9% of the cells will have the right number of chromosomes,” said Jason Sheltzer, assistant professor of surgery at Yale School of Medicine and senior author of the study, adding, “But we’ve known for over 100 years that nearly all cancers are aneuploid.”

ALSO READ: cancer can occur at any time or age; symptoms and warning signs to look out for

However, it was unclear what role extra chromosomes played in cancer for instance, whether they cause cancer or are caused by it.

“For a long time, we could observe aneuploidy but not manipulate it. We just didn’t have the right tools,” said Sheltzer, who is also a researcher at Yale cancer Center, adding, “But in this study, we used the gene-engineering technique CRISPR to develop a new approach to eliminate entire chromosomes from cancer cells, which is an important technical advance. Being able to manipulate aneuploid chromosomes in this way will lead to a greater understanding of how they function.”

The study was co-led by former lab members Vishruth Girish, now an M.D.-Ph.D. student at Johns Hopkins School of Medicine, and Asad Lakhani, now a postdoctoral researcher at Cold Spring Harbor Laboratory.

Using their newly developed approach which they dubbed Restoring Disomy in Aneuploid cells using CRISPR Targeting, or ReDACT the researchers targeted aneuploidy in melanoma, gastric cancer, and ovarian cell lines. Specifically, they removed an aberrant third copy of the long portion also known as the “q arm” of chromosome 1, which is found in several types of cancer, is linked to disease progression, and occurs early in cancer development.

“When we eliminated aneuploidy from the genomes of these cancer cells, it compromised the malignant potential of those cells and they lost their ability to form tumors,” said Sheltzer

Based on this finding, the researchers proposed cancer cells may have an “aneuploidy addiction” — a name referencing earlier Research that discovered that eliminating oncogenes, which can turn a cell into a cancer cell, disrupts cancers’ tumor-forming abilities. This finding led to a model of cancer growth called “oncogene addiction.”

When investigating how an extra copy of chromosome 1q might promote cancer, the researchers found that multiple genes stimulated cancer cell growth when they were overrepresented — because they were encoded on three chromosomes instead of the typical two.

This overexpression of certain genes also pointed the researchers to a vulnerability that might be exploited to target cancers with aneuploidy.

Previous Research has shown that a gene encoded on chromosome 1, known as UCK2, is required to activate certain drugs. In the new study, Sheltzer and his colleagues found that cells with an extra copy of chromosome 1 were more sensitive to those drugs than were cells with just two copies, because of the overexpression of UCK2.

Further, they observed that this sensitivity meant that the drugs could redirect cellular evolution away from aneuploidy, allowing for a cell population with normal chromosome numbers and, therefore, less potential to become cancerous. When researchers created a mixture with 20 per cent aneuploid cells and 80% normal cells, aneuploid cells took over: after nine days, they made up 75 per cent of the mixture. But when the researchers exposed the 20 per cent aneuploid mixture to one of the UCK2-dependent drugs, the aneuploid cells comprised just 4% of the mix nine days later.

“This told us that aneuploidy can potentially function as a therapeutic target for cancer,” said Sheltzer, adding, “Almost all cancers are aneuploid, so if you have some way of selectively targeting those aneuploid cells, that could, theoretically, be a good way to target cancer while having minimal effect on normal, non-cancerous tissue.”

More Research needs to be done before this approach can be tested in a clinical trial. But Sheltzer aims to move this work into animal models, evaluate additional drugs and other aneuploidies, and team up with pharmaceutical companies to advance toward clinical trials.

“We’re very interested in clinical translation,” said Sheltzer, adding, “So we’re thinking about how to expand our discoveries in a therapeutic direction.”

This story has been published from a wire agency feed without modifications to the text. Only the headline has been changed.

[ad_2]

Source link

Reps 4 Ryan

[ad_1]

Each year, cancerCare hosts “Do Something for cancerCare,” an annual DIY event where people create their own fundraising activities to raise money and give back to the organization which impacted their cancer journey, or helped a loved one during their experience.

As we launch this year’s Do Something campaign, we wanted to share a story about a group of young men who are doing something in memory of their friend:

alt text

In Fairfield, Connecticut, a group of childhood friends shared an unbreakable bond with Ryan Van Zandt, who was “anything but boring and knew how to entertain those around him,” shared Ryan’s friend, Conor. From childhood to his early twenties, His contagious smile, humor and kindness endeared him to everyone who met him.

It was Ryan’s love of sports and his second diagnosis of a rare form of cancer that led his friends to start “Reps 4 Ryan” in 2015. Combining golf and fitness, the group organized a local golf tournament at the Fairchild Wheeler Golf Course, along with a viral social media challenge.

alt text

“Each and every day had more and more people posting pictures and videos of them throwing reps up in the gym in their Reps 4 Ryan gear,” said Conor. This online presence became so large that it eventually caught the attention of a few Miami Dolphins football players, Ryan’s favorite NFL football team.

At only 25 years old, “to see Ryan receive his second diagnosis was not just devastating, but aggravating at the same time. That’s two times too many and two times more than most people have to go through such an experience.”

“All of those horrible feelings were quickly channeled into motivation to act for Ryan and his tremendous family.” Conor added that “as sad of a time as it was for us with Ryan’s health, it was an incredibly special thing to see so many people band together. Short on energy and strength due to his ailing health at the time, Ryan rallied and joined everyone at the course for that first tournament in 2015.”

alt text

When Ryan passed away in 2016, his friends channeled their feelings of grief and loss into Reps 4 Ryan, now an annual tradition that continues to make an impact. Drawing over 100+ participants each fall, the funds raised at the tournament go towards cancerCare‘s support services and cancer research. Reps 4 Ryan is no longer just an event – it’s a reunion, a celebration and a way to remember the warmth of their family member and friend. It brings Ryan’s community back each year, honoring his memory and the enduring bonds they share.

Ryan’s mother, Lorette, added that he “inspired more than just the Reps 4 Ryan team.” Two books were actually written about him. “Everyone has grieved in different ways,” she said. “But largely, those around him have found the outlets of continuing to help others and connect more with their community as the most positive and helpful way to confront our devastating loss.”

In honoring Ryan’s spirit, Reps 4 Ryan exemplifies the impact a close-knit community can wield as a force for good. “There’s a tremendous buzz around this tournament for so many people and that buzz is something each of us are proud to be a part of and we’re confident that Ryan would love knowing how much he is still loved and missed by all.”



[ad_2]

Source link

Prof Dr. Mario Diaz-Fluorescent tamoxifen derivatives as biophotonic probes for the study of human



This speech was delivered by Prof Dr. Mario Diaz, Universidad de La Laguna, Spain during the International Conference on Oncology and Cancer Research that was Organized by Pencis on16th Edition of Oncology Summit | 21-23 August 2023 | Berlin, Germany

More information – https://oncologyandcancerresearch.blogspot.com/

International Conference on Oncology and Cancer Research:- https://oncology.pencis.com/
Award Nomination link: https://x-i.me/oan
Abstract Submission link: https://x-i.me/srimonco

For Inquiries: oncology@pencis.com

#shorts #shortsvideo #breastcancer #prostatecancer #lungcancer #coloncancer #ovariancancer #pancreaticcancer #leukemia #lymphoma #OncologyConference #CancerResearch #OncologyAwards #CancerTreatment #OncologyCommunity #CancerCare #OncologyEducation #CancerSurvivorship #OncologyInnovation #CancerAwareness #OncologyLeadership #CancerPrevention #OncologyExcellence #CancerBreakthroughs #OncologyCollaboration #CancerAdvancements #OncologyImpact #CancerPatientsFirst #OncologyFuture #OncologyInspiration #CancerFighters #OncologyHeroes #CancerAwarenessMonth #OncologyProgress #CancerSolutions #OncologyExperts #CancerSurvivors #shorts #shortsvideo #cancerConference #OncologyConference #pencis #oncologyconference #CardioOnc #radonc #medonc #caxtx #GeriOnc #psyonc #oncorn #hsronc #camets #cancer #fuckcancer #cancersucks #breastcancerawareness #breastcancer #cancermemes #cancerousmemes #cancersurvivor #cancerawareness #cancerdemama #breastcancerawarenessmonth #cancerresearch #fightcancer #childhoodcancerawareness #beatcancer #childhoodcancer #cancerseason #breastcancersurvivor #cancerfree #cancerfighter #cancerous #fcancer #cancerwarrior #teamcancer #ovariancancer #americancancersociety #standuptocancer #cancerresearchuk #cancersupport #skincancer #cancermeme #cancer #feminismiscancer #curecancer #anticancer #cancerzodiac #prostatecancer #cancers #fucancer #pediatriccancer #cancerawareness #beatcancer #cancersucks #cancerresearch #cancerfighter #cancerwarrior #cancertreatment #cancersurvivor #cancerprevention #cancerawarenessmonth #cancerpatientsupport #breastcancer #prostatecancer #lungcancer #coloncancer #ovariancancer #pancreaticcancer #leukemia #lymphoma #melanoma #braincancer #childhoodcancer #cancerfree #oncology #cancercare #cancerdiagnosis #cancerribbon #cancerjourney

CONNECT HERE:-

Facebook : https://www.facebook.com/Conference-101261931798599
twitter :https://twitter.com/Samirabellil
pinterest : https://in.pinterest.com/OncologyandCancerResearch/
Blog :https://oncologyandcancerresearch.blogspot.com/
tumblr :https://www.tumblr.com/blog/view/cancer-researcher
instagram :https://www.instagram.com/oncology_researcher/
linkedin : https://www.linkedin.com/in/cathenna-malia-a20834219/

source

Ms. Rafiah Kanwal, University of Management and Technology, Best Researcher Award, Pakistan



The International Conference on Oncology and Cancer Research is an event that brings together researchers, healthcare professionals, and experts from the field of oncology and cancer research to discuss the latest developments and advancements in the field. The conference provides a platform for sharing new ideas, scientific knowledge, and research findings among the participants. The conference usually includes keynote speeches, plenary sessions, oral presentations, poster sessions, and workshops. The conference topics may include, but are not limited to, the following areas of cancer research: Basic cancer research, Clinical trials and studies, Cancer prevention and early detection, Cancer diagnosis and treatment, Cancer therapies and new treatments,Cancer epidemiology and statistics, Cancer informatics and technology, Cancer rehabilitation and palliative care, Cancer policy and advocacy. The International Conference on Oncology and Cancer Research is an opportunity for professionals from various backgrounds to come together and collaborate on ways to improve the diagnosis, treatment, and overall management of cancer.

More information – https://oncologyandcancerresearch.blogspot.com/

International Conference on Oncology and Cancer Research:- https://oncology.pencis.com/
Award Nomination link: https://x-i.me/oan
Abstract Submission link: https://x-i.me/srimonco

For Inquiries: oncology@pencis.com

#breastcancer #prostatecancer #lungcancer #coloncancer #ovariancancer #pancreaticcancer #leukemia #lymphoma #OncologyConference #CancerResearch #OncologyAwards #CancerTreatment #OncologyCommunity #CancerCare #OncologyEducation #CancerSurvivorship #OncologyInnovation #CancerAwareness #OncologyLeadership #CancerPrevention #OncologyExcellence #CancerBreakthroughs #OncologyCollaboration #CancerAdvancements #OncologyImpact #CancerPatientsFirst #OncologyFuture #OncologyInspiration #CancerFighters #OncologyHeroes #CancerAwarenessMonth #OncologyProgress #CancerSolutions #OncologyExperts #CancerSurvivors #shorts #shortsvideo #cancerConference #OncologyConference #pencis #oncologyconference #CardioOnc #radonc #medonc #caxtx #GeriOnc #psyonc #oncorn #hsronc #camets #cancer #fuckcancer #cancersucks #breastcancerawareness #breastcancer #cancermemes #cancerousmemes #cancersurvivor #cancerawareness #cancerdemama #breastcancerawarenessmonth #cancerresearch #fightcancer #childhoodcancerawareness #beatcancer #childhoodcancer #cancerseason #breastcancersurvivor #cancerfree #cancerfighter #cancerous #fcancer #cancerwarrior #teamcancer #ovariancancer #americancancersociety #standuptocancer #cancerresearchuk #cancersupport #skincancer #cancermeme #cancer #feminismiscancer #curecancer #anticancer #cancerzodiac #prostatecancer #cancers #fucancer #pediatriccancer #cancerawareness #beatcancer #cancersucks #cancerresearch #cancerfighter #cancerwarrior #cancertreatment #cancersurvivor #cancerprevention #cancerawarenessmonth #cancerpatientsupport #breastcancer #prostatecancer #lungcancer #coloncancer #ovariancancer #pancreaticcancer #leukemia #lymphoma #melanoma #braincancer #childhoodcancer #cancerfree #oncology #cancercare #cancerdiagnosis #cancerribbon #cancerjourney

CONNECT HERE:-

Facebook : https://www.facebook.com/Conference-101261931798599
twitter :https://twitter.com/Samirabellil
pinterest : https://in.pinterest.com/OncologyandCancerResearch/
Blog :https://oncologyandcancerresearch.blogspot.com/
tumblr :https://www.tumblr.com/blog/view/cancer-researcher
instagram :https://www.instagram.com/oncology_researcher/
linkedin : https://www.linkedin.com/in/cathenna-malia-a20834219/

source

City of Hope scientists develop targeted chemotherapy able to kill all solid tumors in preclinical research

[ad_1]

The City of Hope-developed small molecule AOH1996 targets a cancerous variant of the protein PCNA. In its mutated form, PCNA is critical in DNA replication and repair of all expanding tumors. Here we see untreated cancer cells (left) and cancer cells treated with AOH1996 (right) undergoing programmed cell death (violet). (Photo credit: City of Hope)

Most targeted therapies focus on a single pathway, which enables wily cancer to mutate and eventually become resistant, said Linda Malkas, Ph.D., professor in City of Hope’s Department of Molecular Diagnostics and Experimental Therapeutics and the M.T. & B.A. Ahmadinia Professor in Molecular oncology. However, the cancer-killing pill Malkas has been developing over the past two decades, AOH1996, targets a cancerous variant of PCNA, a protein that in its mutated form is critical in DNA replication and repair of all expanding tumors.

“PCNA is like a major airline terminal hub containing multiple plane gates. Data suggests PCNA is uniquely altered in cancer cells, and this fact allowed us to design a drug that targeted only the form of PCNA in cancer cells. Our cancer-killing pill is like a snowstorm that closes a key airline hub, shutting down all flights in and out only in planes carrying cancer cells,” said Malkas, senior author of the new study published in Cell Chemical Biology today. “Results have been promising. AOH1996 can suppress tumor growth as a monotherapy or combination treatment in cell and animal models without resulting in toxicity. The investigational chemotherapeutic is currently in a Phase 1 clinical trial in humans at City of Hope.”

AOH1996 has been effective in preclinical Research treating cells derived from breast, prostate, brain, ovarian, cervical, skin and lung cancers and is exclusively licensed by City of Hope to RLL, LLC, a Biotechnology company that Malkas co-founded and holds financial interest in.

The researchers tested AOH1996, a small molecule PCNA inhibitor, in more than 70 cancer cell lines and several normal control cells. They found that AOH1996 selectively kills cancer cells by disrupting the normal cell reproductive cycle. It targets something called transcription replication conflicts, which occur when mechanisms responsible for gene expression and genome duplication collide. The investigational therapy prevented cells with damaged DNA from dividing in G2/M phase and from making a copy of faulty DNA in S phase. As a result, AOH1996 caused cancer cell death (apoptosis), but it did not interrupt the reproductive cycle of healthy stem cells.

“No one has ever targeted PCNA as a therapeutic because it was viewed as ‘Conference-registration-gbp/”>Undruggable,’ but clearly City of Hope was able to develop an investigational medicine for a challenging protein target,” said Long Gu, Ph.D., lead author of the study and an associate Research professor in the Department of Molecular Diagnostics and Experimental Therapeutics at Beckman Research Institute of City of Hope. “We discovered that PCNA is one of the potential causes of increased nucleic acid replication errors in cancer cells. Now that we know the problem area and can inhibit it, we will dig deeper to understand the process to develop more personalized, targeted cancer medicines.”

Interestingly, experiments showed that the investigational pill made cancer cells more susceptible to chemical agents that cause DNA or chromosome damage, such as the Award-call-for-profile/”>Chemotherapy drug cisplatin, hinting that AOH1996 could become a useful tool in combination therapies as well as for the development of new chemotherapeutics.

“City of Hope has world leaders in cancer Research. They also have the infrastructure to drive translational drug discovery from the laboratory into the clinic for patients in need,” said Daniel Von Hoff, M.D., study co-author and a distinguished professor at Translational Genomics Research Institute, part of City of Hope.

City of Hope’s groundbreaking translational Research history includes developing the technology underlying synthetic human insulin, a breakthrough in diabetes management, and monoclonal antibodies, which are integral to widely used, lifesaving cancer drugs, such as trastuzumab, rituximab and cetuximab.

As a next step, the researchers will look to better understand the mechanism of action to further improve the ongoing clinical trial in humans. Individuals interested in the Phase 1 clinical trial should review the eligibility requirements at clinicaltrials.gov. If eligible, call 626-218-1133 or visit City of Hope’s clinical trials webpage.

The Cell Chemical Biology study entitled “Small Molecule Targeting of Transcription-Replication Conflict for Selective Award-call-for-profile/”>Chemotherapy” was supported by the Department of Defense (W81XWH-11-1-0786, W81XWH-19-1-0326 under BC181474 and BC181474P1), National Institutes of Health/National cancer Institute (R01 CA121289, R01 CA225843), St Baldrick’s Foundation, the Alex Lemonade Stand Foundation, Tobacco-Related Disease Research Program (TRDRP-T31IP626), Melanoma Research Foundation (MRF-717178), the ANNA Fund, RDL Foundation, Analytical Pharmacology Core supported by the National cancer Institute of the National Institutes of Health (P30CA033572).

[ad_2]

Source link

Florida dermatologists warn about how to spot the skin cancer that killed Jimmy Buffett

[ad_1]

skin <a href=cancer” title=”Credit: CC0 Public Domain” width=”800″ height=”530″/>
Credit: CC0 Public Domain

Florida dermatologists say the skin cancer that killed Jimmy Buffett is becoming more common in the Sunshine State and urge residents to look out for a few unique features.

While rare, the aggressive skin cancer pops up most often in skin areas exposed to the sun, such as the face, scalp or neck. People who are fair-skinned, older than 50, and exposed regularly to the sun are at higher risk of developing Merkel cell carcinoma. The key to survival is finding out early, and acting quickly.

People diagnosed and treated for this form of skin cancer while it is still localized have a five-year survival rate of 75%, but once it spreads to a distant organ, the survival rate plunges to only 24%.

What to look for

In Delray Beach, dermatologist Steven Hacker says he has many patients he is treating or following that have Merkel cell carcinoma.

“It looks like a very non-specific bump that is flesh-colored or reddish blue and can be the size of an eraser tip on a pencil,” he said. “It needs to be biopsied to make a diagnosis. The sooner it’s caught, the better your chances are.”

If something looks like a pimple or bug bite and doesn’t go away, get checked by a dermatologist, he said. It some cases, the original bump spawns more nearby.

Merkel cell carcinoma can be aggressive, especially when it spreads to distant parts of the body. It is the second most common cause of skin cancer-related death, after melanoma.

“While it’s rare in the U.S., in Florida we actually see a lot of it,” said Dr. Michael Kasper, director of radiation oncology with Lynn cancer Institute, part of Baptist Health, at Boca Raton Regional Hospital. “We see it a couple of times a month.”

And, while it is more common in men, Kasper says they see women with it too. “With the population living in Florida, one of biggest things that sets us apart is the suppressed immune system that happens as we age.”

Kasper said with Merkel, the nodule below the skin’s surface tends to be hard or firm, although not at all painful. “It can grow fairly quickly. Sometimes, doctors who don’t know what it is will try to drain it and nothing will come out,” he said. “It should not be drained. If you know what you are looking at, you know not to drain it. If you find it early and it is localized, most of the time it can be cured.”

A virus called Merkel cell polyomavirus may play a role in causing most cases of the cancer, Kasper said. Just how this virus causes Merkel cell carcinoma is still unknown.

When a biopsy shows Merkel cell carcinoma, doctors will remove the nodule, but also do radiation to completely get rid of cancerous tissue and reduce the chance of recurrence. There also will be a biopsy of the nearby lymph node and a full body PET scan to see if the cancer has spread to organs. Oncologists recommend immunotherapy if the Merkel cell carcinoma has spread or is inoperable. In 2019, the federal government approved an new immunotherapy to treat people with advanced Merkel cell carcinoma.

Other skin cancers

Although skin cancer is the most common cancer diagnosis is the U.S., most Americans fail to get checked regularly, according to an online survey in January of more than 2,000 people by Prevent cancer Foundation. The survey found 70% of Americans 21 and older have not had a skin check in the past year.

The three most common types of skin cancer are basal cell carcinoma, squamous cell carcinoma, and melanoma. Anyone, regardless of skin color, can get these, although those with freckles, fair skin and light hair are most at risk.

Basal cell carcinomas typically grow slowly and don’t spread to other areas of the body. But if this cancer isn’t treated, the cells can expand deeper and penetrate into nerves and bones. Squamous cell cancer usually is not life-threatening, but if not treated, can grow large or spread to other parts of the body. Melanoma is the most serious type of the more common skin cancers because it is most likely to grow and spread.

Merkel cell carcinoma is is 40 times rarer than melanoma. Buffett, the “Margaritaville” singer and legendary Florida beach fan, had been battling it for four years.

About a dozen other rare types of skin cancer also exist.

Legendary Jamaican singer, musician and songwriter Bob Marley died of a rare skin cancer when he was only 36 years old. He had acral lentiginous melanoma that appeared as a dark spot under his toenail. ALM typically develops under nails, on the soles of the feet or the palms of the hands and is the most common form of melanoma found in people of color.

“If you have a spot that is evolving or changing rapidly over weeks or months have it checked out,” said Dr. Charles Dunn, a dermatology resident with ADCS Orlando Dermatology “You can get skin cancer in areas that are not even exposed to sun.”

Dunn said with all skin cancers, but particularly with Merkel, “time is of the essence.” Early detection, he said, results in better survival statistics.

Be vigilant, get checked

Dr. Rajiv Nathoo, a dermatologist and complex clinic director for Advanced Dermatology and Cosmetic Surgery Clinics in Orlando, said there is a lot of misdiagnosis with skin cancer and advises Floridians to get their regular skin check with board-certified dermatologists. “The general public should be aware of red flags and seek out care, but skin cancer is complex and it’s why we exist as field.” Nathoo said he has a patient in hospice with Merkel who was misdiagnosed, and the skin cancer has now spread. “It’s a big deal because of the mortality statistics. A third of the time with Merkel it has metastasized by the time it’s diagnosed.”

Although genetics and an individual’s immune system play a role, dermatologists recommend wearing sunscreen, avoiding sunburns, and staying indoors during the hottest times of the day. In addition, Nicotinamide, a form of vitamin B3, has been shown to reduce the number of skin cancers when taken orally, but the benefits are lost once you stop taking it, according to a report in Harvard Health Publishing.

“Talk with your dermatologist to see if you are a candidate for Nicotinamide,” Hacker said.

While dermatologists recommend annual skin checks, those over 65 might consider twice a year.

“It’s really crucial to now what’s normal for you and your skin,” said Heather Macky, senior director of cancer prevention and early detection at the Prevent cancer Foundation. “If you notice a mole, freckle or bump that’s changing in size, shape or color, bring it to the attention of your provider, and don’t wait.”

©2023 South Florida Sun Sentinel.

Distributed by Tribune Content Agency, LLC.

Citation:
Florida dermatologists warn about how to spot the skin cancer that killed Jimmy Buffett (2023, September 9)
retrieved 9 September 2023
from https://medicalxpress.com/news/2023-09-florida-dermatologists-skin-cancer-jimmy.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.



[ad_2]

cancer-jimmy.html”>Source link

Revolutionizing Cancer Treatment: City of Hope's Targeted Chemotherapy Breakthrough



City of Hope scientists develop targeted chemotherapy able to kill all solid tumors in preclinical research

More information – https://oncologyandcancerresearch.blogspot.com/

International Conference on Oncology and Cancer Research:- https://oncology.pencis.com/
Award Nomination link: https://x-i.me/oan
Abstract Submission link: https://x-i.me/srimonco

For Inquiries: oncology@pencis.com

#shorts #shortsvideo #breastcancer #prostatecancer #lungcancer #coloncancer #ovariancancer #pancreaticcancer #leukemia #lymphoma #OncologyConference #CancerResearch #OncologyAwards #CancerTreatment #OncologyCommunity #CancerCare #OncologyEducation #CancerSurvivorship #OncologyInnovation #CancerAwareness #OncologyLeadership #CancerPrevention #OncologyExcellence #CancerBreakthroughs #OncologyCollaboration #CancerAdvancements #OncologyImpact #CancerPatientsFirst #OncologyFuture #OncologyInspiration #CancerFighters #OncologyHeroes #CancerAwarenessMonth #OncologyProgress #CancerSolutions #OncologyExperts #CancerSurvivors #shorts #shortsvideo #cancerConference #OncologyConference #pencis #oncologyconference #CardioOnc #radonc #medonc #caxtx #GeriOnc #psyonc #oncorn #hsronc #camets #cancer #fuckcancer #cancersucks #breastcancerawareness #breastcancer #cancermemes #cancerousmemes #cancersurvivor #cancerawareness #cancerdemama #breastcancerawarenessmonth #cancerresearch #fightcancer #childhoodcancerawareness #beatcancer #childhoodcancer #cancerseason #breastcancersurvivor #cancerfree #cancerfighter #cancerous #fcancer #cancerwarrior #teamcancer #ovariancancer #americancancersociety #standuptocancer #cancerresearchuk #cancersupport #skincancer #cancermeme #cancer #feminismiscancer #curecancer #anticancer #cancerzodiac #prostatecancer #cancers #fucancer #pediatriccancer #cancerawareness #beatcancer #cancersucks #cancerresearch #cancerfighter #cancerwarrior #cancertreatment #cancersurvivor #cancerprevention #cancerawarenessmonth #cancerpatientsupport #breastcancer #prostatecancer #lungcancer #coloncancer #ovariancancer #pancreaticcancer #leukemia #lymphoma #melanoma #braincancer #childhoodcancer #cancerfree #oncology #cancercare #cancerdiagnosis #cancerribbon #cancerjourney

CONNECT HERE:-

Facebook : https://www.facebook.com/Conference-101261931798599
twitter :https://twitter.com/Samirabellil
pinterest : https://in.pinterest.com/OncologyandCancerResearch/
Blog :https://oncologyandcancerresearch.blogspot.com/
tumblr :https://www.tumblr.com/blog/view/cancer-researcher
instagram :https://www.instagram.com/oncology_researcher/
linkedin : https://www.linkedin.com/in/cathenna-malia-a20834219/

source